CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation
Coco de Koning(University Medical Center Utrecht), Jaap Jan Boelens(Wilhelmina Children's Hospital), Jurgen Langenhorst(Princess Máxima Center), Celina L. Szanto(University Medical Center Utrecht), Elizabeth Klein(Memorial Sloan Kettering Cancer Center), Maria Cancio(Memorial Sloan Kettering Cancer Center), Birgitta Versluijs(Utrecht University), Caroline A. Lindemans(University Medical Center Utrecht), Susan E. Prockop(Memorial Sloan Kettering Cancer Center), Kevin J. Curran(Memorial Sloan Kettering Cancer Center), Barbara Spitzer(Memorial Sloan Kettering Cancer Center), Farid Boulad(Memorial Sloan Kettering Cancer Center), Dorine Bresters(Willem-Alexander Kinderziekenhuis), Wouter J.W. Kollen(Princess Máxima Center), Nancy A. Kernan(Memorial Sloan Kettering Cancer Center), Marc Bierings(University Medical Center Utrecht), Andromachi Scaradavou(NewYork–Presbyterian Hospital), Stefan Nierkens(Utrecht University), Mirjam E. Belderbos(Princess Máxima Center), Richard J. O’Reilly(Memorial Sloan Kettering Cancer Center), Ichelle van Roessel(Memorial Sloan Kettering Cancer Center), Alwin D. R. Huitema(The Netherlands Cancer Institute)
Cited by 70
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
|New England Journal of Medicine|1993|848
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
|Nature Genetics|2020|739